Related Experiment Videos
Infrequent BCL10 mutations in B-cell non-Hodgkin's lymphomas
H Takahashi1, Y Hosokawa, R Suzuki
1Laboratory of Chemotherapy, Aichi Cancer Center Research Institute, Nagoya.
Japanese Journal of Cancer Research : Gann
|February 9, 2000
Summary
BCL10 gene mutations are rare in B-cell non-Hodgkin
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The BCL10 gene, identified in MALT lymphomas, is implicated in various tumors.
- Somatic mutations in BCL10 have been observed in diverse cancer types.
Purpose of the Study:
- To determine the frequency and types of BCL10 mutations in primary B-cell non-Hodgkin's lymphomas (NHL).
- To assess the role of BCL10 mutations in the pathogenesis of NHL.
Main Methods:
- Analysis of 139 NHL cases, including MALT lymphomas, follicular B-cell lymphomas (FCL), and diffuse large B-cell lymphomas (DLBL).
- Utilized Polymerase Chain Reaction Single-Strand Conformation Polymorphism (PCR-SSCP) and sequencing to detect mutations.
- Identified polymorphic sequence variants within the BCL10 gene.
Main Results:
- Identified four nucleotide changes in FCL and one in DLBL.
- No BCL10 mutations were detected in the MALT lymphoma cohort.
- Discovered three polymorphic variants in BCL10.
Conclusions:
- Somatic mutations of the BCL10 gene are infrequent in B-cell NHL.
- BCL10 mutations do not appear to be a common driver in the molecular pathogenesis of B-cell NHL.